Journey Medical Corporation (DERM)

USD 7.48

(1.22%)

Revenue Summary of Journey Medical Corporation

  • Journey Medical Corporation's latest annual revenue in 2023 was 79.18 Million USD , up 7.48% from previous year.
  • Journey Medical Corporation's latest quarterly revenue in 2024 Q1 was 13.03 Million USD , down -14.6% from previous quarter.
  • Journey Medical Corporation reported a annual revenue of 73.66 Million USD in annual revenue 2022, up 16.69% from previous year.
  • Journey Medical Corporation reported a annual revenue of 63.13 Million USD in annual revenue 2021, up 41.78% from previous year.
  • Journey Medical Corporation reported a quarterly revenue of 13.03 Million USD for 2024 Q1, down -14.6% from previous quarter.
  • Journey Medical Corporation reported a quarterly revenue of 79.18 Million USD for 2023 FY, up 7.48% from previous quarter.

Annual Revenue Chart of Journey Medical Corporation (2023 - 2014)

Historical Annual Revenue of Journey Medical Corporation (2023 - 2014)

Year Revenue Revenue Growth
2023 79.18 Million USD 7.48%
2022 73.66 Million USD 16.69%
2021 63.13 Million USD 41.78%
2020 44.53 Million USD 27.52%
2019 34.92 Million USD -17.52%
2018 42.33 Million USD 832.37%
2017 4.54 Million USD -79.89%
2016 22.58 Million USD 209.38%
2015 7.3 Million USD 0.0%
2014 7.3 Million USD 0.0%

Peer Revenue Comparison of Journey Medical Corporation

Name Revenue Revenue Difference
Aquestive Therapeutics, Inc. 50.58 Million USD -56.537%
Collegium Pharmaceutical, Inc. 566.76 Million USD 86.029%
Dynavax Technologies Corporation 232.28 Million USD 65.912%
Esperion Therapeutics, Inc. 116.33 Million USD 31.936%
Intra-Cellular Therapies, Inc. 464.37 Million USD 82.949%
Pacira BioSciences, Inc. 674.97 Million USD 88.269%
PainReform Ltd. - USD -Infinity%
Petros Pharmaceuticals, Inc. 5.82 Million USD -1259.94%
Sunshine Biopharma, Inc. 24.09 Million USD -228.65%
Sunshine Biopharma, Inc. 24.09 Million USD -228.65%
SCYNEXIS, Inc. 140.14 Million USD 43.499%
Silver Spike Investment Corp. 11.72 Million USD -575.483%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -4005.84%
Alpha Teknova, Inc. 36.68 Million USD -115.846%
Alvotech 91.43 Million USD 13.401%
ANI Pharmaceuticals, Inc. 486.81 Million USD 83.735%
Bright Green Corporation 401.49 Thousand USD -19621.737%
Embecta Corp. 1.12 Billion USD 92.935%
Safety Shot Inc 202.67 Thousand USD -38968.93%
Procaps Group, S.A. 409.92 Million USD 80.684%
Cosmos Health Inc. 53.37 Million USD -48.343%
Theratechnologies Inc. 81.76 Million USD 3.159%
Harrow Health, Inc. 130.19 Million USD 39.182%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -521.759%
Biofrontera Inc. 34.07 Million USD -132.4%
DURECT Corporation 8.54 Million USD -826.31%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 86.967%
Cronos Group Inc. 88.84 Million USD 10.873%
OptiNose, Inc. 70.98 Million USD -11.543%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 82.115%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD -1115.705%
Organogenesis Holdings Inc. 433.14 Million USD 81.719%
Guardion Health Sciences, Inc. 12.24 Million USD -546.452%
Cumberland Pharmaceuticals Inc. 39.55 Million USD -100.192%
Radius Health, Inc. 2.88 Billion USD 97.253%
Universe Pharmaceuticals INC 32.3 Million USD -145.076%
ProPhase Labs, Inc. 44.38 Million USD -78.4%
Phibro Animal Health Corporation 1.01 Billion USD 92.219%
Procaps Group S.A. 409.92 Million USD 80.684%
TherapeuticsMD, Inc. 1.3 Million USD -5981.49%
Viatris Inc. 15.42 Billion USD 99.487%
Rockwell Medical, Inc. 83.61 Million USD 5.299%
Aytu BioPharma, Inc. 81 Million USD 2.248%
SIGA Technologies, Inc. 139.91 Million USD 43.409%
Tilray Brands, Inc. 788.94 Million USD 89.964%
Lifecore Biomedical, Inc. 128.26 Million USD 38.266%
Shineco, Inc. 9.8 Million USD -707.816%
PetIQ, Inc. 1.1 Billion USD 92.815%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -659741.667%
Neurocrine Biosciences, Inc. 1.88 Billion USD 95.804%
Alimera Sciences, Inc. 80.75 Million USD 1.948%
Assertio Holdings, Inc. 152.06 Million USD 47.931%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Clever Leaves Holdings Inc. 17.41 Million USD -354.619%
Cyclo Therapeutics, Inc. 1.07 Million USD -7256.06%
Avadel Pharmaceuticals plc 27.96 Million USD -183.163%
Hempacco Co., Inc. 4.04 Million USD -1857.195%
Talphera, Inc. 651 Thousand USD -12062.98%
Alvotech 91.43 Million USD 13.401%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 74.991%
Lantheus Holdings, Inc. 1.29 Billion USD 93.892%
Currenc Group, Inc. 53.25 Million USD -48.682%
Kamada Ltd. 144.75 Million USD 45.301%
Indivior PLC 1.09 Billion USD 92.756%
Evoke Pharma, Inc. 5.18 Million USD -1428.405%
Flora Growth Corp. 76.07 Million USD -4.088%
Cyclo Therapeutics, Inc. 1.07 Million USD -7256.06%
Evolus, Inc. 202.08 Million USD 60.818%
HUTCHMED (China) Limited 837.99 Million USD 90.551%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 87.712%
Akanda Corp. 2.16 Million USD -3565.699%